Our numbers

During 2021, the IBiS has continued to attract significant external resources and has maintained an upward evolution in its scientific production. These indicators reflect a notable and progressive positioning of the IBiS within Spanish biomedical research. In 2021, a unique new cutting-edge infrastructure for the molecular study of diseases has been funded. The Singular Infrastructure for Biomedical Research in Individual Cells (ISIBiSCI) has funds to facilitate its use by researchers from other centers in five autonomous communities, and has been financed with 1.35 million euros from the Carlos III Health Institute under the European Recovery, Transformation and Resilience funds. There is no doubt that the progress that is being made is thanks to the commitment and dedication of the research staff, technical staff, management and maintenance staff, as well as the support of the consortium institutions. All of this is allowing the progressive increase in the quality of scientific production, an objective on which we are increasingly focusing.

The year 2021 has been a year of confirmation of budgetary stability and the commitment to economic support of the consortium institutions. This situation has to serve as a support point to undertake very important challenges aimed at improving the scientific quality of the IBiS: the recruitment and retention of scientific talent in all the research areas of the institute, the growth of financing and the expansion of spaces. of the IBiS.

Personal IBiS

• 57%

  43%

• 1 Mujer
• 2 Hombre

Categoría personal IBiS

• 84%

  15%

  3%

• 1 Personal investigador
• 2 Personal técnico
• 3 Personal de gestión

Distribución de Grupos por Área Científica

• 7

  6
  Área Enfermedades Infecciosas y del Sistema Inmunitario

• 15

  7
  Área Neurociencias

• 9

  13
  Área Onco-hematología y Genética

• 4

  1

  12
  Área Patología Cardiovascular y Respiratoria/Otras Patologías Sistémicas

• 5

  2
  Área Enfermedades Hepáticas, Digestivas e Inflamatorias

• 1 Consolidado
• 2 Emergente
• 3 Adscrito

Distribución por ámbito de las Ayudas Competitivas Activas en el 2021

• 33,7%
• 60,0%
• 6,3%

• 1 Autonómicas
• 2 Nacionales
• 3 Internacionales/Europeas

Indicadores Bibliométricos Publicaciones 2021 indexadas JCR

• 53,1%
• 26,1%
• 20,8%
• 24,0%

• 1 Q1
• 2 Q2
• 3 Q3/Q4
• 4 D1